- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 115,235 | 30.07.24 21:59:43 | -12,545 | -9,82% | 115,230 | 115,250 | 125,775 | 127,780 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 110,050 | 30.07.24 21:59:39 | +1,300 | +1,20% | 109,600 | 110,040 | 109,800 | 108,750 |
